Skip to main content
. 2021 Dec;499:None. doi: 10.1016/j.jim.2021.113160

Fig. 4.

Fig. 4

SARS-CoV-2 spike and RBD total IgG endpoint titers evaluated for three individual samples (A, B, C) as well as positive WHO reference sample, pooled positive (CCPP) and negative (NHPP) control samples. Dashed line represents lower limit of detection.